Navigation Links
Panel Demands FDA Action to Address Dramatic Increases in Skin Cancer in U.S.

Panelists highlight need for immediate action to implement rigorous sunscreen standards and approve more effective sunscreen ingredients to combat lethal sun damage

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Today keynote speaker Congresswoman Nita Lowey (NY-18) joined with experts from New York Presbyterian Hospital; the Skin Cancer Foundation; 2006 Miss Maryland, a skin cancer survivor; Fallene LTD, and Ciba Corporation to call on the Food and Drug Administration (FDA) to address the dramatic rise in skin cancer rates in the United States. The panel was organized by Citizens for Sun Protection (CFSP), a coalition of national, state, and local organizations and individuals advocating for U.S. sunscreen standards that meet or exceed the sunburn and skin cancer protection requirements available in Europe.

As much of the country moves into the colder, winter months, the panel sought to turn up the heat on a health care crisis that requires immediate action before another summer passes. Panelists called upon the FDA to set a strong sunscreen standard requiring protection from both UVB and UVA rays, with transparent labeling, and approve photostable, broad-spectrum sunscreen ingredients to defend against both UVB and UVA rays.

"The FDA continues to delay action on implementing sunscreen standards which would provide more effective and informative labeling, an important line of defense against the damaging rays of the sun," said Rep. Lowey. "The American public is under-protected and operating with a false sense of security in the face of the life-threatening dangers of sun exposure. I stand in full support of initiatives that would reduce the occurrence of skin cancer."

In her remarks, Rep. Lowey expressed deep concern with the FDA's delayed action to provide Americans with more complete and informative sunscreen standards and labeling, and their failure to approve highly effective sunscreen ingredients available in every other country except the U.S. The New York Congresswoman sought to focus the FDA's attention on rising skin cancer rates which many public health experts point to as a growing health care crisis, particularly in young women.

"People need to take better precautions when spending time outdoors and the U.S. government needs to be supportive of standards and ingredients that could further protect Americans from all the sun's rays -- UVB and UVA alike," said melanoma survivor and 2006 Miss Maryland Brittany Lietz. "Speaking from experience, we are not as protected as we think we are."

In 1999, the FDA recognized the significant need for more effective UVA radiation filters. Since then, concerns regarding the U.S. public health risks from UVA radiation have continued to mount. In August 2007, the FDA issued a proposed rule to amend the OTC Sunscreen Drug Product Monograph by promoting a UVA labeling standard. To date, action has not been taken to finalize the improved standards.

Following the panel, a Citizen's Petition signed by the panelists and other leading skin cancer experts, medical professionals and sunscreen manufacturers was presented to the FDA. The petition calls on the FDA to immediately act to approve sunscreen ingredients that provide a photostable, broad-spectrum UV filter with excellent protection against UVA rays. Previous attention had focused on UVB exposure and the link to sunburn. Recent evidence shows that UVA rays are even more damaging and linked to skin cancer. The panel cited:

  • Skin cancer is the most prevalent form of cancer with more than 1.2 million cases diagnosed annually. Accumulating evidence indicates that radiation across the entire ultraviolet spectrum (UVA and UVB) contributes to skin cancers including melanoma, a major U.S. public health threat and the deadliest form of skin cancer with over 60,000 cases diagnosed and more than 8,000 deaths each year
  • Modern sunscreens combining high levels of protection across the UVA and UVB spectra can be expected to be 4-fold more effective in preventing melanoma than sunscreens providing just UVB protection
  • The American public needs to be educated on the importance of using these broad spectrum products; the FDA must implement sunscreen standards that clearly outline the amount of protection that sunscreen products offer against cancer-causing rays; and the agency needs to expedite the now stagnant review of sunscreen filters under the Time & Extent Application (TEA) process. FDA action is required to issue an Enforcement Action so that broad-spectrum photostable UVA/UVB sunscreen active ingredients can be incorporated into products for the U.S. population without further delay.

Under TEA consideration before the FDA is Ciba(R) Tinosorb(R), a photostable, broad-spectrum UV filter that provides protection against UVA rays. Ingredients such as this have been approved in every major sunscreen market outside of the U.S., including countries in Europe, Australia, Brazil, Canada, Japan and Mexico. Panelists addressed the need for the FDA to approve sunscreen ingredients that provide a photostable, broad-spectrum UV filter for use in U.S. without further delay.

"It is an incredible disservice to the American population that ingredients to improve sunscreens exist yet remain unavailable in the U.S. market," said Catherine Ehrenberger, President of Home & Personal Care for Ciba. "The FDA must address this critical health issue and expedite the approval of new sunscreen filters before another summer passes."


    Banks Willis

SOURCE Citizens for Sun Protection
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Patient Safety Authority Board of Directors Names Infection Advisory Panel
4. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
7. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
8. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
9. FDA Panel Mulls Ban on Kids Cold Medicines
10. FDA Panel Weighs Ban on Kids Cold Medicines
11. FDA Panel Recommends Ban on Cold Medicines for Kids
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater Boston donated an expansive, ... of Ronald McDonald House Charities® (RMHC®). This donation was made in an effort to ... Boston since its inception. , “We believe strongly in the Ronald McDonald House Charities, ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a technology company ... health programs and interventions via mobile devices that provide a framework for the ...
(Date:10/13/2015)... ... 13, 2015 , ... Element Blue ™, a leading ... company, RightSensor™ LLC, an Internet of Things (IoT) hardware supplier that delivers custom ... approach for customers requiring sensor hardware for critical data environments. , RightSensor™, working ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... NavaFit Inc. ... helps individuals find others to train with, participate in local fitness & sporting ... and Google Play. , “As high medical costs drive us to get more serious ...
(Date:10/13/2015)... (PRWEB) , ... October 13, ... ... Postnatal Omega-3, a first-of-its kind product that targets the unique health needs ... Omega-3” of the American Pregnancy Association ( ), utilizes Nordic Naturals’ ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)...   Rosa & Co. LLC , the leading ... (QSP)/ PhysioPD™ , today announced that Dr. Christina ... the QSP Congress Meeting on October 20 ...  The conference focuses on the uses and benefits ... is entitled "Using Mechanistic Physiological Models in Drug Development: ...
(Date:10/13/2015)... 13, 2015 China Jo-Jo Drugstores, ... Jo-Jo "), a leading China-based retail, wholesale and online ... own online and retail pharmacies, announced preliminary half year ... online pharmacy through , growing 438% year ... 25%. China Jo-Jo,s online sales ...
(Date:10/13/2015)... N.C. , Oct. 13, 2015  Yesterday Congresswoman ... Influenza Vaccines Holly Springs manufacturing site located in ... 2014, the facility has produced Flucelvax ® (Influenza ... the potential for faster start-up and is not reliant ... CSL Limited acquired the influenza vaccines business of Novartis ...
Breaking Medicine Technology: